Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Tennessee | 18,974 Studies Near You

Clinical TrialsTennessee

Clinical Trials in Tennessee

Discover 18,974 clinical trials near Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3941-3960 of 18,974 trials

Active not recruitingComparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple MyelomaThis phase II trial compares the combination of selinexor, daratumumab and hyaluronidase-fihj (daratumumab), velcade (bortezomib), and dexamethasone (Dara-SVD) to the usual…NCT06169215·Irvine, California and 26 others

Find Trials by Condition in Tennessee

Breast Cancerin Tennessee Lung Cancerin Tennessee Prostate Cancerin Tennessee Colorectal Cancerin Tennessee Melanomain Tennessee Leukemiain Tennessee Lymphomain Tennessee Pancreatic Cancerin Tennessee Ovarian Cancerin Tennessee Brain Cancerin Tennessee

Data from ClinicalTrials.govTerms

CompletedA Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender IndividualsThe purpose of this study is to evaluate the vaccine efficacy (VE) of a heterologous vaccine regimen utilizing Ad26.Mos4.HIV and aluminum phosphate-adjuvanted Clade C gp140 and…NCT03964415·Birmingham, Alabama and 52 others

CompletedEscitalopram in Adult Patients With Major Depressive DisorderThis is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram in adult patients (18 to 65 years of age) with moderate to severe depression.NCT00668525·Phoenix, Arizona and 44 others

CompletedSafety and Tolerability of Initiating LCZ696 in Heart Failure PatientsThe purpose of this study is to assess the safety and tolerability of initiating LCZ696 in heart failure patients with reduced ejection fraction (HF-rEF) using conservative…NCT01922089·Anchorage, Alaska and 104 others

CompletedSafe Options for ACL RecoveryThe purpose of the proposed work is to test a brief opioid exposure reduction program (ACL-OERP) designed to improve health literacy about opioid use following surgeries.NCT04225468·Memphis, Tennessee

CompletedCollecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsThe purpose of this study is to collect and store brain tissue samples and blood from children with brain cancer that will be tested in the laboratory.NCT00919750·Birmingham, Alabama and 186 others

CompletedSafety Evaluation of 3K3A-APC in Ischemic StrokeThe purpose of this study was to evaluate the safety, pharmacokinetics (PK) and preliminary efficacy of multiple ascending intravenous doses of 3K3A-APC, a Recombinant Variant of…NCT02222714·Los Angeles, California and 14 others

CompletedStudy to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced CancerThis is a Phase 1, open-label, multi-center, first time in human study of AMP-224 in adult patients with cancer that is not responding to standard therapy.NCT01352884·Detroit, Michigan and 3 others

CompletedA Study of Semorinemab in Patients With Moderate Alzheimer's DiseaseThis Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study will evaluate the clinical efficacy, safety, pharmacokinetics, and pharmacodynamics…NCT03828747·Garden Grove, California and 48 others

Active not recruitingTo Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.This study is to assess the efficacy and safety of olaparib monotherapy versus olaparib in combination with an inhibitor of ATR (Ataxia-Telangiectasia Mutated (ATM) and…NCT03330847·Birmingham, Alabama and 140 others

CompletedFludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerThis phase I/II trial is studying how well fludeoxyglucose F 18 PET scan, CT scan, and ferumoxtran-10 MRI scan finds lymph node metastasis before undergoing chemotherapy and…NCT00416455·Los Angeles, California and 32 others

CompletedPhase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to…NCT01951625·Fountain Valley, California and 156 others

TerminatedA Phase Ib Study of LXH254-centric Combinations in NSCLC or MelanomaTo characterize safety and tolerability and identify a recommended dose and regimen for the LXH254 in combination with LTT462 or trametinib or ribociclib.NCT02974725·San Diego, California and 31 others

CompletedAnti-VEGF Treatment for Prevention of PDR/DMEMultiple studies have implicated vascular endothelial growth factor VEGF as a major causative factor in human eye diseases characterized by neovascularization including…NCT02634333·Phoenix, Arizona and 84 others

CompletedGene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically RemovedRATIONALE: Exposing tumor cells to the p53 gene may improve the body's ability to fight non-small cell lung cancer.NCT00003649·Nashville, Tennessee and 2 others

CompletedA Study to Evaluate the Safety of STS101 in the Acute Treatment of MigraineStudy STS101-003 is a multi-center, multiple dose (PRN), open-label, 12-month study to evaluate the safety and tolerability of STS101 (dihydroergotamine nasal powder) in the acute…NCT04406649·Encino, California and 43 others

TerminatedThe Effect of Dietary Fiber on Food LikingThis study will investigate the effects of different fermenting fibers on liking of foods.NCT03241238·Knoxville, Tennessee

RecruitingHaplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell TransplantationThe investigators want to learn if CMV- and ADV-specific T-cells (cells that fight infections) isolated (selected) from a donor using an automated medical device can be a safe…NCT05664126·Memphis, Tennessee

CompletedBLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyThis is a randomized, parallel, multi-center, single-blind study, comparing BLI-800 to an FDA approved bowel preparation in adult subjects undergoing colonoscopy.NCT00503815·Anaheim, California and 9 others

CompletedComparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel DiseaseThe purpose of this study is to compare the clinical findings involving the small bowel obtained with the Capso Vision Video Capsule Device to those results obtained with the…NCT01787825·Scottsdale, Arizona and 6 others

PreviousPage 198 of 949Next

Diabetes

in Tennessee

Heart Diseasein Tennessee